Today, the co-chairs of the fiscally-responsible, Democratic Blue Dog Coalition—Reps. Jim Costa (D-CA), Henry Cuellar (D-TX), and Daniel Lipinski (D-IL)—released the following statement in response to the introduction of the Alexander-Murray health care bill in the Senate:
Insert text here...
Today, the co-chairs of the fiscally-responsible Democratic Blue Dog Coalition—Reps. Jim Costa (D-CA), Henry Cuellar (D-TX), and Daniel Lipinski (D-IL)—released the following statement in response to President Trump’s decision to sign an executive order to end cost-sharing reduction (CSR) payments:
The fiscally-responsible Blue Dog Coalition has endorsed “Solutions Over Politics,” a five-part proposal of ways to stabilize the individual health insurance market and improve the Affordable Care Act. The proposal was spearheaded by Blue Dog member Congressman Kurt Schrader (OR-05) less than two weeks ago.
Today, the Democratic Blue Dog Coalition endorsed the Lower Drug Costs Through Competition Act, which was introduced by Blue Dog Congressman Kurt Schrader (D-OR) and Congressman Gus Bilirakis (R-FL) last week.
Washington – Today, while the House Oversight Committee holds a bipartisan hearing with officials from Mylan, titled “Reviewing the Rising Price of EpiPens,” the Blue Dog Coalition endorsed a bill that could prevent dramatic price hikes like that of the EpiPen. H.R. 4784, the Lower Drug Costs Through Competition Act helps streamline the FDA approval process on generic drugs, and encourages competition by providing incentives for more generics to come to the market.
WASHINGTON – The Blue Dog Coalition announced their support for H.R. 2911, the Small Business Healthcare Relief Act. The legislation seeks to roll back problematic regulations put in place to implement the Affordable Care Act that fine businesses with less than 50 employees for offering Healthcare Reimbursement Agreements (HRAs) to reimburse their employees for healthcare-related expenses. Employees can use these funds to purchase healthcare on the individual market or for out-of-pocket medical expenses.